Background The DNA damage response (DDR) safeguards genome integrity, and its disruption contributes to cancer development, therapy response, and resistance. Large-scale sequencing has identified thousands of DDR gene variants in tumors, but the functional consequences of most remain unclear, limiting their clinical interpretation and application. Results We previously developed CRISPR-dependent base editing screens to functionally characterize DDR variants in breast-derived cell lines. Here, we extend this work to triple-negative breast cancer by performing a large-scale base editing screen in MDA-MB-231 cells. We assessed the impact on cellular fitness of ∼11,000 single-guide RNAs (sgRNAs) targeting the coding sequences of 27 DDR genes, primarily involved in homologous recombination (HR) and inter-strand crosslink repair (ICLR). The resulting dataset integrates mutation-associated effects with clinical annotations, enabling functional stratification of variants of uncertain significance. Conclusion Combined with our previous datasets from MCF7 and MCF10A breast-derived cell lines, these results create a standardized, cross-comparable data that uncover both shared and context-specific genetic dependencies. Ultimately, we anticipate this resource will advance the functional interpretation of DDR variants, thereby facilitating the development of precision oncology approaches.
Building similarity graph...
Analyzing shared references across papers
Loading...
Wardah Masud
Centre For Human Genetics
Ludovica Russo
Molecular Oncology (United States)
Vincent Chapdelaine-Trépanier
Centre For Human Genetics
Frontiers in Cell and Developmental Biology
SHILAP Revista de lepidopterología
Columbia University
McGill University
The University of Texas MD Anderson Cancer Center
Building similarity graph...
Analyzing shared references across papers
Loading...
Masud et al. (Thu,) studied this question.
synapsesocial.com/papers/69ca1210883daed6ee094d92 — DOI: https://doi.org/10.3389/fcell.2026.1714494